clofibric acid has been researched along with Weight Reduction in 11 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Furthermore, severe hypertriglyceridemia is associated with an increased risk of acute pancreatitis, irrespective of its effect on risk of cardiovascular disease." | 2.44 | Hypertriglyceridemia: its etiology, effects and treatment. ( Al-Shali, KZ; Hegele, RA; Yuan, G, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 10 (90.91) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardenas, GA | 1 |
| Lavie, CJ | 1 |
| Cardenas, V | 1 |
| Milani, RV | 1 |
| McCullough, PA | 1 |
| Merkel, M | 1 |
| Benz, R | 1 |
| Suter, PM | 1 |
| Ashen, MD | 1 |
| Blumenthal, RS | 1 |
| Moser, M | 1 |
| Falkner, B | 1 |
| Weber, MA | 1 |
| Keilson, LM | 1 |
| Yuan, G | 1 |
| Al-Shali, KZ | 1 |
| Hegele, RA | 1 |
| Brunzell, JD | 1 |
| Yavasoglu, I | 1 |
| Kadikoylu, G | 1 |
| Bolaman, Z | 1 |
| Röggla, G | 1 |
| Fasan, M | 1 |
| Kapiotis, S | 1 |
| Holub, BJ | 1 |
| Muls, E | 1 |
| Van Gaal, L | 1 |
| Autier, P | 1 |
| Vansant, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment Study for Severe High-Density Lipoprotein Deficiency[NCT00458055] | 19 participants (Actual) | Interventional | 2006-11-30 | Completed | |||
| Effect of Tomato Consumption on Serum High Density Lipoprotein-cholesterol Levels. A Randomized, Open-label, Single Blind, Clinical Trial[NCT01342666] | 50 participants (Actual) | Interventional | 2009-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
To evaluate the effect of two daily tomatoes consumption on HDL-c levels. (NCT01342666)
Timeframe: Baseline and after one month
| Intervention | mg/dL (Mean) | |
|---|---|---|
| Baseline HDL-c | Final HDL-c | |
| Cucumber Consumption | 36.8 | 35.8 |
| Tomato Consumption | 36.5 | 41.6 |
6 reviews available for clofibric acid and Weight Reduction
| Article | Year |
|---|---|
The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
Topics: Apolipoprotein A-I; Atherosclerosis; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; C | 2008 |
[Diabetic dyslipoproteinemia: beyond LDL].
Topics: Atherosclerosis; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Chy | 2009 |
[Low HDL-cholesterol, high triglycerides--well known but often ignored].
Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Cholesterol, HDL; Clofibric A | 2004 |
Clinical practice. Low HDL cholesterol levels.
Topics: Adult; Alcohol Drinking; Cholesterol; Cholesterol, HDL; Clofibric Acid; Diet, Fat-Restricted; Drug T | 2005 |
Clinical practice. Low HDL cholesterol levels.
Topics: Adult; Alcohol Drinking; Cholesterol; Cholesterol, HDL; Clofibric Acid; Diet, Fat-Restricted; Drug T | 2005 |
Clinical practice. Low HDL cholesterol levels.
Topics: Adult; Alcohol Drinking; Cholesterol; Cholesterol, HDL; Clofibric Acid; Diet, Fat-Restricted; Drug T | 2005 |
Clinical practice. Low HDL cholesterol levels.
Topics: Adult; Alcohol Drinking; Cholesterol; Cholesterol, HDL; Clofibric Acid; Diet, Fat-Restricted; Drug T | 2005 |
Hypertriglyceridemia: its etiology, effects and treatment.
Topics: Clofibric Acid; Coronary Artery Disease; Diet; Exercise; Humans; Hydroxymethylglutaryl-CoA Reductase | 2007 |
Clinical practice. Hypertriglyceridemia.
Topics: Adult; Aged; Apolipoproteins B; Cholesterol; Clofibric Acid; Combined Modality Therapy; Diet Therapy | 2007 |
5 other studies available for clofibric acid and Weight Reduction
| Article | Year |
|---|---|
The metabolic syndrome--what is it and how should it be managed?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clofibric Acid; Humans; Hydroxymethylglutaryl-CoA | 2006 |
Treating hypertriglyceridemia.
Topics: Adult; Clofibric Acid; Coronary Artery Disease; Diet; Exercise; Heparin; Humans; Hydroxymethylglutar | 2007 |
Treating hypertriglyceridemia.
Topics: Clofibric Acid; Coronary Artery Disease; Diet; Exercise; Humans; Hydroxymethylglutaryl-CoA Reductase | 2007 |
Treating hypertriglyceridemia.
Topics: Clofibric Acid; Coronary Artery Disease; Diet; Exercise; Fatty Acids, Omega-3; Humans; Hydroxymethyl | 2007 |
Effects of initial BMI and on-treatment weight change on the lipid-lowering efficacy of fibrates.
Topics: Body Mass Index; Clofibric Acid; Female; Fenofibrate; Fibric Acids; Gemfibrozil; Humans; Hypercholes | 1997 |